Romosozumab efficacy in postmenopausal women with no prior fracture who fulfill criteria for very high fracture risk
Journal article
McClung, Michael R., Betah, Donald, Deignan, Cynthia, Shi, Yifei, Timoshanko, Jen and Cosman, Felicia. (2023). Romosozumab efficacy in postmenopausal women with no prior fracture who fulfill criteria for very high fracture risk. Endocrine Practice. 29(9), pp. 716-722. https://doi.org/10.1016/j.eprac.2023.06.011
Authors | McClung, Michael R., Betah, Donald, Deignan, Cynthia, Shi, Yifei, Timoshanko, Jen and Cosman, Felicia |
---|---|
Abstract | Objective Methods Results Conclusion |
Keywords | American Association of Clinical; Endocrinology (AACE); bone mineral density (BMD); osteoporosis; very high fracture risk (VHFR); treatment sequence |
Year | 2023 |
Journal | Endocrine Practice |
Journal citation | 29 (9), pp. 716-722 |
Publisher | American Association of Clinical Endocrinologists |
ISSN | 1530-891X |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.eprac.2023.06.011 |
PubMed ID | 37406858 |
Scopus EID | 2-s2.0-85169308309 |
Open access | Published as ‘gold’ (paid) open access |
Page range | 716-722 |
Funder | Amgen, Inc. |
UCB Pharma | |
Astellas Pharma | |
Publisher's version | License File Access Level Open |
Output status | Published |
Publication dates | |
Online | 11 Sep 2023 |
Publication process dates | |
Accepted | 28 Jun 2023 |
Deposited | 04 Apr 2025 |
Additional information | © 2023 AACE. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
https://acuresearchbank.acu.edu.au/item/9192y/romosozumab-efficacy-in-postmenopausal-women-with-no-prior-fracture-who-fulfill-criteria-for-very-high-fracture-risk
Download files
Publisher's version
OA_McClung_2023_Romosozumab_efficacy_in_postmenopausal_women_with.pdf | |
License: CC BY-NC-ND 4.0 | |
File access level: Open |
7
total views1
total downloads0
views this month0
downloads this month